NovAccess Global Inc Sustainability Reports
NovAccess Global Inc. operates as a biopharmaceutical company specializing in the research and development of novel immunotherapies to treat brain tumors, including glioblastoma.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG001SC0BS5
1 reports from 2022 to 2022
Company Profile
NovAccess Global Inc. operates as a biopharmaceutical company specializing in the research and development of novel immunotherapies to treat brain tumors, including glioblastoma.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
